1. Cirillo, P, Pellegrino, G, Conte, S, et al. Fructose induces prothrombotic phenotype in human endothelial cells: a new role for “added sugar” in cardio-metabolic risk. J Thromb Thrombolysis. 2015; 40, 444–451.
2. Taskinen, MR, Soderlund, S, Bogl, LH, et al. Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity. J Intern Med. 2017; 282, 187–201.
3. Bringhenti, I, Schultz, A, Rachid, T, et al. An early fish oil-enriched diet reverses biochemical, liver and adipose tissue alterations in male offspring from maternal protein restriction in mice. J Nutr Biochem. 2011; 22, 1009–1014.
4. Frantz, ED, Aguila, MB, Pinheiro-Mulder Ada, R, Mandarim-de-Lacerda, CA. Transgenerational endocrine pancreatic adaptation in mice from maternal protein restriction in utero. Mech Ageing Dev. 2011; 132, 110–116.
5. Barker, DJ. Developmental origins of adult health and disease. J Epidemiol Community Health. 2004; 58, 114–115.
6. Toop, CR, Muhlhausler, BS, O’Dea, K, Gentili, S. Impact of perinatal exposure to sucrose or high fructose corn syrup (HFCS-55) on adiposity and hepatic lipid composition in rat offspring. J Physiol. 2017; 595, 4379–4398.
7. Ng, SF, Lin, RC, Laybutt, DR, et al. Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring. Nature. 2010; 467, 963–966.
8. Ornellas, F, Souza-Mello, V, Mandarim-de-Lacerda, CA, Aguila, MB. Combined parental obesity augments single-parent obesity effects on hypothalamus inflammation, leptin signaling (JAK/STAT), hyperphagia, and obesity in the adult mice offspring. Physiol Behav. 2016; 153, 47–55.
9. Ornellas, F, Carapeto, PV, Mandarim-de-Lacerda, CA, Aguila, MB. Obese fathers lead to an altered metabolism and obesity in their children in adulthood: review of experimental and human studies. J Pediatr (Rio J). 2017; 93, 551–559.
10. Rodriguez, L, Panadero, MI, Rodrigo, S, et al. Liquid fructose in pregnancy exacerbates fructose-induced dyslipidemia in adult female offspring. J Nutr Biochem. 2016; 32, 115–122.
11. Tain, YL, Chan, JY, Hsu, CN. Maternal fructose intake affects transcriptome changes and programmed hypertension in offspring in later life. Nutrients. 2016; 8, 757–766.
12. Sharma, N, Li, L, Ecelbarger, CM. Sex differences in renal and metabolic responses to a high-fructose diet in mice. Am J Physiol Renal Physiol. 2015; 308, F400–F410.
13. Schultz, A, Neil, D, Aguila, MB, Mandarim-de-Lacerda, CA. Hepatic adverse effects of fructose consumption independent of overweight/obesity. Int J Mol Sci. 2013; 14, 21873–21886.
14. Reeves, PG, Nielsen, FH, Fahey, GC Jr.. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993; 123, 1939–1951.
15. Wolterink-Donselaar, IG, Meerding, JM, Fernandes, C. A method for gender determination in newborn dark pigmented mice. Lab Anim (NY). 2009; 38, 35–38.
16. Marconi, AM, Paolini, C, Buscaglia, M, et al. The impact of gestational age and fetal growth on the maternal-fetal glucose concentration difference. Obstet Gynecol. 1996; 87, 937–942.
17. Schultz, A, Barbosa-da-Silva, S, Aguila, MB, Mandarim-de-Lacerda, CA. Differences and similarities in hepatic lipogenesis, gluconeogenesis and oxidative imbalance in mice fed diets rich in fructose or sucrose. Food Funct. 2015; 6, 1684–1691.
18. Kang, DH, Ha, SK. Uric acid puzzle: dual role as anti-oxidantand pro-oxidant. Electrolyte Blood Press. 2014; 12, 1–6.
19. Stanhope, KL, Schwarz, JM, Keim, NL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009; 119, 1322–1334.
20. Bargut, TCL, Santos, LP, Machado, DGL, Aguila, MB, Mandarim-de-Lacerda, CA. Eicosapentaenoic acid (EPA) vs. docosahexaenoic acid (DHA): effects in epididymal white adipose tissue of mice fed a high-fructose diet. Prostaglandins Leukot Essent Fatty Acids. 2017; 123, 14–24.
21. Sondergaard, L. Homology between the mammalian liver and the drosophila fat body. Trends Genet. 1993; 9, 193.
22. Wree, A, Kahraman, A, Gerken, G, Canbay, A. Obesity affects the liver – the link between adipocytes and hepatocytes. Digestion. 2011; 83, 124–133.
23. Papa, S, Bubici, C, Zazzeroni, F, Franzoso, G. Mechanisms of liver disease: cross-talk between the NF-kappaB and JNK pathways. Biol Chem. 2009; 390, 965–976.
24. Wullaert, A, van Loo, G, Heyninck, K, Beyaert, R. Hepatic tumor necrosis factor signaling and nuclear factor-kappaB: effects on liver homeostasis and beyond. Endocr Rev. 2007; 28, 365–386.
25. Paschos, P, Paletas, K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia. 2009; 13, 9–19.
26. Tilg, H, Moschen, AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010; 52, 1836–1846.
27. Douard, V, Ferraris, RP. Regulation of the fructose transporter GLUT5 in health and disease. Am J Physiol Endocrinol Metab. 2008; 295, E227–E237.
28. Tappy, L, Le, KA, Tran, C, Paquot, N. Fructose and metabolic diseases: new findings, new questions. Nutrition. 2010; 26, 1044–1049.
29. Abdelmalek, MF, Suzuki, A, Guy, C, et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology. 2010; 51, 1961–1971.
30. Takahashi, Y, Shinoda, A, Furuya, N, et al. Perilipin-mediated lipid droplet formation in adipocytes promotes sterol regulatory element-binding protein-1 processing and triacylglyceride accumulation. PLoS One. 2013; 8, e64605.
31. Liu, J, Wang, R, Desai, K, Wu, L. Upregulation of aldolase B and overproduction of methylglyoxal in vascular tissues from rats with metabolic syndrome. Cardiovasc Res. 2011; 92, 494–503.
32. Vasdev, S, Stuckless, J. Role of methylglyoxal in essential hypertension. Int J Angiol. 2010; 19, e58–e65.
33. DiNicolantonio, JJ, Lucan, SC. The wrong white crystals: not salt but sugar as aetiological in hypertension and cardiometabolic disease. Open Heart. 2014; 1, e000167.
34. Zhang, X, Zhang, JH, Chen, XY, et al. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation. Antioxid Redox Signal. 2015; 22, 848–870.
35. Gallou-Kabani, C, Junien, C. Nutritional epigenomics of metabolic syndrome: new perspective against the epidemic. Diabetes. 2005; 54, 1899–1906.
36. Soubry, A. Epigenetic inheritance and evolution: a paternal perspective on dietary influences. Prog Biophys Mol Biol. 2015; 118, 79–85.
37. Li, N, Shen, Q, Hua, J. Epigenetic remodeling in male germline development. Stem Cells Int. 2016; 2016, 3152173.
38. Zhao, H, Zhao, Y, Ren, Y, et al. Epigenetic regulation of an adverse metabolic phenotype in polycystic ovary syndrome: the impact of the leukocyte methylation of PPARGC1A promoter. Fertil Steril. 2017; 107, 467–474, e465.
39. Koo, HY, Miyashita, M, Cho, BH, Nakamura, MT. Replacing dietary glucose with fructose increases ChREBP activity and SREBP-1 protein in rat liver nucleus. Biochem Biophys Res Commun. 2009; 390, 285–289.
40. Denechaud, PD, Dentin, R, Girard, J, Postic, C. Role of ChREBP in hepatic steatosis and insulin resistance. FEBS Lett. 2008; 582, 68–73.
41. Nomura, K, Yamanouchi, T. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. J Nutr Biochem. 2012; 23, 203–208.
42. Rasmussen, BB, Holmback, UC, Volpi, E, et al. Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle. J Clin Invest. 2002; 110, 1687–1693.